产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 98% | 现货 | |||
| 5mg | 98% | 现货 | |||
| 10mg | 98% | 现货 | |||
| 25mg | 98% | 现货 | |||
| 50mg | 98% | 现货 | |||
| 100mg | 98% | 现货 | |||
| 250mg | 98% | 现货 | |||
| 1g | 98% | 现货 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 98% | 现货 | |||
| 5mg | 98% | 现货 | |||
| 10mg | 98% | 现货 | |||
| 25mg | 98% | 现货 | |||
| 50mg | 98% | 现货 | |||
| 100mg | 98% | 现货 | |||
| 250mg | 98% | 现货 | |||
| 1g | 98% | 现货 |
CAS No. |
1238697-26-1 |
|---|---|
中文名称 |
1-(2-氟-4-(1H-吡唑-1-基)苯基)-5-甲氧基-3-(1-苯基-1H-吡唑-5-基)哒嗪-4(1H)-酮 |
英文名称 |
1-(2-Fluoro-4-(1H-pyrazol-1-yl)phenyl)-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4(1H)-one |
别名 |
Balipodect | TAK-063 | 1238697-26-1 | 1-(2-fluoro-4-(1H-pyrazol-1-yl)phenyl)-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4(1H)-one | Balipodect [INN] | Balipodect [USAN] | TAK 063 | Balipodect [WHO-DD] | TAK063 | 1-[2-Fluoro-4-(1h-Pyrazol-1-Yl)phenyl]-5-Methoxy-3-(1-Ph |
标准英文名 |
1-(2-fluoro-4-(1H-pyrazol-1-yl)phenyl)-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4(1H)-one |
分子式 |
C23H17FN6O2 |
分子量 |
428.43 |
精确分子量 |
428.14 |
SMILES |
FC1=CC(N2N=CC=C2)=CC=C1N3N=C(C4=CC=NN4C5=CC=CC=C5)C(C(OC)=C3)=O |
标准SMILES |
COC1=CN(N=C(C1=O)C1=CC=NN1C1C=CC=CC=1)C1=CC=C(C=C1F)N1C=CC=N1 |
性状 |
Solid |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
KVHRYLNQDWXAGI-UHFFFAOYSA-N |
危险类别(旧) |
H302,H315,H319,H335 |
存储要求 |
Keep in dark place,Sealed in dry,Room Temperature,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A),Specific target organ toxicity, single exposure; Respiratory tract irritation (Category 3) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|